Oreste ­Gentilini

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

Viviana Galimberti, Bernard F. Cole, Stefano Zurrida et al. · The Lancet Oncology · 2013 · 1.2K citations · Full text

Ibcsg 23–01, Surgical Pathology, Sentinel-node Micrometastases +5

Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial

Umberto Veronesi, Roberto Orecchia, Patrick Maisonneuve et al. · The Lancet Oncology · 2013 · 758 citations

Surgical Oncology, External Radiotherapy, Radiation Therapy +8

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 533 citations

Surgical Oncology, Breast Oncology, Medicine +7

Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes

Oreste ­Gentilini, Edoardo Botteri, Claudia Sangalli et al. · JAMA Oncology · 2023 · 409 citations · Full text

Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: entinel node vs bservation after axillary ltraSou )

Oreste ­Gentilini, Umberto Veronesi · The Breast · 2012 · 407 citations · Full text